CC
PFE icon

Centiva Capital’s Pfizer PFE Stock Holding History

Centiva Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.93M Sell
140,000
-250,000
-64% -$6.66M 0.03% 315
2025
Q4 		$9.71M Buy
390,000
+250,000
+179% +$6.3M 0.08% 165
2025
Q3 		$3.57M Hold
140,000
– – 0.03% 284
2025
Q2 		$3.39M Buy
+140,000
New +$3.26M 0.06% 209
2024
Q4 		– Sell
-14,200
Closed -$411K – 2230
2024
Q3 		$411K Sell
14,200
-26,400
-65% -$770K 0.01% 1384
2024
Q2 		$1.14M Sell
40,600
-14,500
-26% -$399K 0.02% 712
2024
Q1 		$1.53M Sell
55,100
-123,000
-69% -$3.41M 0.04% 448
2023
Q4 		$5.13M Buy
178,100
+157,600
+769% +$4.76M 0.12% 155
2023
Q3 		$680K Buy
+20,500
New +$725K 0.02% 813
2023
Q2 		– Sell
-10,200
Closed -$416K – 1906
2023
Q1 		$416K Sell
10,200
-41,500
-80% -$1.79M 0.01% 915
2022
Q4 		$2.65M Buy
51,700
+35,000
+210% +$1.68M 0.07% 273
2022
Q3 		$731K Sell
16,700
-5,000
-23% -$243K 0.01% 742
2022
Q2 		$1.14M Buy
21,700
+10,700
+97% +$545K 0.03% 550
2022
Q1 		$570K Sell
11,000
-120,900
-92% -$6.27M 0.01% 917
2021
Q4 		$7.79M Buy
131,900
+124,720
+1,737% +$6.18M 0.16% 120
2021
Q3 		$311K Buy
7,180
+5,180
+259% +$229K 0.02% 774
2021
Q2 		$78K Sell
2,000
-22,500
-92% -$875K ﹤0.01% 1276
2021
Q1 		$887K Sell
24,500
-301,600
-92% -$10.7M 0.03% 402
2020
Q4 		$12M Buy
+326,100
New +$12M 0.47% 36
2020
Q3 		– Sell
-105
Closed -$3K – 838
2020
Q2 		$3K Hold
105
– – ﹤0.01% 645
2020
Q1 		$3K Buy
+105
New +$3.58K ﹤0.01% 571
2019
Q1 		– Sell
-64,294
Closed -$2.66M – 357
2018
Q4 		$2.66M Hold
64,294
– – 0.21% 67
2018
Q3 		$2.69M Buy
64,294
+50,170
+355% +$1.93M 0.23% 66
2018
Q2 		$487K Sell
14,124
-47,535
-77% -$1.62M 0.1% 59
2018
Q1 		$2.08M Buy
+61,659
New +$2.12M 0.5% 18

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Centiva Capital's PFE Position: Q1 2026 in Review

Centiva Capital increased its Pfizer (PFE) stake by 89% in Q1 2026, buying an estimated $6.47M and bringing the position to 515,495 shares worth $14.5M. The position accounts for 0.11% of the portfolio, ranked #135.

Centiva Capital first reported a position in PFE in Q3 2018 and has held it in 25 quarters since. The position peaked at $22.1M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Centiva Capital held 515,495 shares of Pfizer worth $14.5M as of Q1 2026.
  • Centiva Capital bought 243,137 Pfizer shares in Q1 2026, an estimated $6.47M.
  • Pfizer made up 0.11% of Centiva Capital's portfolio in Q1 2026, its #135 holding.
  • Centiva Capital first reported a position in Pfizer in Q3 2018 and has held it in 25 quarters since.
  • Centiva Capital's Pfizer position peaked at $22.1M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.